Screening clopidogrel non-responders and optimizing antiplatelet therapy after acute and elective percutaneous coronary intervention

被引：0
|
作者：
Lee, S. [1 ]
Vargova, K. [2 ]
Hizoh, I. [2 ]
Gulacsi-Bardos, P. [1 ]
Horvath, Z. S. [1 ]
Kovacs, A. [1 ]
Toth-Zsamboki, E. [2 ]
Preda, I. [2 ]
Kiss, R. G. [2 ]
机构：
[1] Hungarian Acad Sci, Res Grp Inflammat Biol & Immunogen, Budapest, Hungary
[2] State Hlth Ctr, Dept Cardiol, Budapest, Hungary
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 419
页数：1
相关论文
共 50 条
  • [1] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [2] Antiplatelet therapy of acute coronary syndromes with percutaneous coronary intervention: are aspirin and clopidogrel sufficient?
    Hoffmann, S
    Klamroth, R
    Pollich, C
    Landgraf, H
    Andresen, D
    EUROPEAN HEART JOURNAL, 2004, 25 : 88 - 88
  • [3] Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
    Ten Berg J.M.
    Thijs Plokker H.W.
    Verheugt F.W.A.
    Trials, 2 (3) : 129 - 140
  • [4] Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
    ten Berg, JM
    Plokker, HWT
    Verheugt, FWA
    CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (03): : 129 - 140
  • [5] HANC SCORE IS A REPLICABLE CLINICAL RISK SCORE FOR OUTCOME PREDICTION OF TAIWANESE CLOPIDOGREL NON-RESPONDERS AFTER PERCUTANEOUS CORONARY INTERVENTION
    Ko, Chen-Yu
    Liu, Ping-Yen
    ATHEROSCLEROSIS, 2024, 395
  • [6] Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Valgimigli, Marco
    Gragnano, Felice
    Branca, Mattia
    Franzone, Anna
    da Costa, Bruno R.
    Baber, Usman
    Kimura, Takeshi
    Jang, Yangsoo
    Hahn, Joo-Yong
    Zhao, Qiang
    Windecker, Stephan
    Gibson, Charles M.
    Watanabe, Hirotoshi
    Kim, Byeong-Keuk
    Song, Young Bin
    Zhu, Yunpeng
    Vranckx, Pascal
    Mehta, Shamir
    Ando, Kenji
    Hong, Sung Jin
    Gwon, Hyeon-Cheol
    Serruys, Patrick W.
    Dangas, George D.
    McFadden, Eugene P.
    Angiolillo, Dominick J.
    Heg, Dik
    Calabro, Paolo
    Juni, Peter
    Mehran, Roxana
    JAMA CARDIOLOGY, 2024, 9 (05) : 437 - 448
  • [7] Optimizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Older Adults
    Khan, Safi U.
    Kleiman, Neal S.
    JAMA NETWORK OPEN, 2024, 7 (03)
  • [8] Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
    Alkhalil, Mohammad
    Dzavik, Vladimir
    Bhatt, Deepak L.
    Mehran, Roxana
    Mehta, Shamir R.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 277 - 293
  • [9] Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
    Mohammad Alkhalil
    Vladimír Džavík
    Deepak L. Bhatt
    Roxana Mehran
    Shamir R. Mehta
    Current Cardiology Reports, 2022, 24 : 277 - 293
  • [10] Antiplatelet Therapy After Percutaneous Coronary Intervention
    Natsuaki, Masahiro
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2022, 86 (05) : 741 - 747
12345